Breaking News

BREAKING: Hospitals and Other Providers Ask HHS to Halt Lilly and Merck’s Clampdowns on 340B; Companies Defend Their Positions

Hospitals and Other Providers Ask HHS to Halt Lilly and Merck’s Clampdowns on 340B; Companies Defend Their Positions

The U.S. Health and Human Services Department (HHS) should halt drug manufacturers Eli Lilly and Merck’s recent separate actions to curtail or

Read More »

Key House Committee Rejects HRSA Request for More Regulatory Authority


A Message from Publisher and CEO Ted Slafsky: Happy Tuesday from sunny Washington, D.C.! I encourage you to read Comprehensive Pharmacy Services’ (CPS) article about its new white paper on navigating the 340B program during the COVID-19

Read More »

HRSA Says its 340B Contract Pharmacy Guidance Is Not Legally Enforceable


A note from Publisher and CEO Ted Slafsky: Attention 340B covered entities! I am honored and excited to be speaking on a virtual panel July 15 hosted by 340B Report sponsor PSG on the latest 340B

Read More »

Eli Lilly Says It Doesn’t Have to Provide 340B-Priced Drugs to Contract Pharmacies

A note from Publisher and CEO Ted Slafsky: Our sponsors are 340B’s industry leaders and we are proud to showcase their innovative solutions and guidance to help you implement and comply with this complex program. Click on the button

Read More »

More Evidence That 340B Program Guidance Is Unenforceable

A note from Publisher and CEO Ted Slafsky: Our sponsors are 340B’s industry leaders and we are proud to showcase their innovative solutions and guidance to help you implement and comply with this complex program. Click on the button

Read More »

Brace Yourselves: A Major 340B Hospital Court Ruling and CMS Proposed Rule Are Coming


A note from Publisher and CEO Ted Slafsky: Happy Tuesday! I hope all is well with everyone and you get to enjoy the upcoming holiday. Our sponsors are 340B’s industry leaders and we are proud to

Read More »

Hospitals Might Not Get 340B Discounts on Drugs Being Investigated as COVID-19 Treatments


A note from Publisher and CEO Ted Slafsky: Please join us in welcoming FQHC 340B to our growing list of 340B Report sponsors. We look forward to partnering with them and having our readers learn

Read More »

MedPAC Report Endnote Sheds Light on Hospital Losses Due to CMS 340B Drug Payment Cuts


Happy Juneteenth from Publisher and CEO Ted Slafsky: Our sponsors are 340B’s industry leaders and we are proud to showcase their innovative solutions and guidance to help you implement and comply with this complex program. Benefits

Read More »

340B Drug Manufacturer Audits: A Q&A with HRSA


A note from 340B Report CEO and Publisher Ted Slafsky: Please join us in welcoming Comprehensive Pharmacy Services to our growing group of 340B Report sponsors! And I hope you enjoy a new column from

Read More »

HRSA Takes Step to Improve 340B Pricing Consistency


A note from 340B Report CEO and Publisher Ted Slafsky: I encourage all of you to read Trellis Rx Chief Pharmacy Officer Jerry Buller’s great article in today’s issue about how 340B health systems can leverage

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer